| For: | Huang KK, Han SS, He LY, Yang LL, Liang BY, Zhen QY, Zhu ZB, Zhang CY, Li HY, Lin Y. Combination therapy (toripalimab and lenvatinib)-associated toxic epidermal necrolysis in a patient with metastatic liver cancer: A case report. World J Clin Cases 2022; 10(11): 3478-3484 [PMID: 35611193 DOI: 10.12998/wjcc.v10.i11.3478] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i11/3478.htm |
| Number | Citing Articles |
| 1 |
Qijie Li, Paola Vignali, Donghao Tang, Giulia Martinelli, Beatrice Fuochi, Rebecca Sparavelli, Anello Marcello Poma, Rossella Bruno, Elisabetta Macerola, Clara Ugolini. Expression and Clinical Significance of CD47 in Colorectal Cancer: A Review. Cancers 2025; 18(1) doi: 10.3390/cancers18010054
|
| 2 |
Xiaoqi Meng, Dansheng Li, Bingrong Zhou, Juan Liu, Yang Xu. Apremilast combined with low-dose corticosteroids for lichenoid drug eruption following programmed cell death protein 1 inhibitor and lenvatinib therapy: A case report. JAAD Case Reports 2026; 72 doi: 10.1016/j.jdcr.2026.03.058
|
| 3 |
|
| 4 |
Jia Zhou, Chuan-Peng Wang, Jun Li, Han-Lin Zhang, Chun-Xia He. Stevens-Johnson syndrome and toxic epidermal necrolysis associated with immune checkpoint inhibitors: a systematic review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1414136
|